If a similar company sells for 11x, does that mean that your company will sell for 11x? Why wouldn’t it? What are the most common causes of valuation differences among companies that seem very similar? Why do some deals not close? What are the items buyers care the most about when screening companies to acquire? What are the most common deal killers? Valuations are high now. Are buyers waiting for them to go down? Let’s hear what our panel has to say.



Bob Kipps, Managing Director, KippsDeSanto

John Song, Managing Director, Baird

Susan Gabay, Managing Director, Houlihan Lokey

Joel Kallett, Managing Director, Clearsight Advisors

Jason Kaufman, President and M&A Practice Lead, The Chertoff Group


Bessemer Trust

Cordia Partners